Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension

Journal of Human Hypertension

Volumn 25, Issue 11, 2011, Pages 672-678

  Vaidya, A ^a   Forman, J P ^a,b   Williams, J S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

25 hydroxyvitamin D; angiotensin II; obesity; renin; vascular; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANGIOTENSIN II; RENIN;

ADULT; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PULSE; OBESITY; PLASMA RENIN ACTIVITY; PREDICTOR VARIABLE; PULSE WAVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; VASCULAR RENIN ANGIOTENSIN SYSTEM ACTIVITY;

ANGIOTENSIN II; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; HUMANS; HYPERTENSION; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; OBESITY; RENIN; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80054057730     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.110     Document Type: Article

References (48)

1. Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 2009; 32(11): 1977-1979.
2. Catenacci VA, Hill JO, Wyatt HR. The obesity epidemic. Clin Chest Med 2009; 30(3): 415-444, vii.
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-281.
4. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: A systematic review. Nat Rev Cardiol 2009; 6(10): 621-630.
5. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304(16): 930-933. (Pubitemid 11101080)
6. Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D et al. ACE, angiotensinogen and obesity: A potential pathway leading to hypertension. J Hum Hypertens 1997; 11(2): 107-111. (Pubitemid 27202252)
7. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997; 10(6): 629-633. (Pubitemid 27293478)
8. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M et al. Weight loss and the renin-angiotensinaldosterone system. Hypertension 2005; 45(3): 356-362.
9. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35(6): 1270-1277. (Pubitemid 30413663)
10. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G et al. The adipose-tissue renin-angiotensin- aldosterone system: Role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35(6): 807-825. (Pubitemid 36379323)
11. Bentley-Lewis R, Adler GK, Perlstein T, Seely EW, Hopkins PN, Williams GH et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab 2007; 92(11): 4472-4475. (Pubitemid 350074772)
12. Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Reninangiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: An integrated view in humans. J Hypertens 2008; 26(5): 831-843. (Pubitemid 351540757)
13. Mazzolai L, Nussberger J, Aubert JF, Brunner DB, Gabbiani G, Brunner HR et al. Blood pressureindependent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 1998; 31(6): 1324-1330. (Pubitemid 28248835)
14. Dluhy RG, Williams GH. Aldosterone-villain or bystander? N Engl J Med 2004; 351(1): 8-10.
15. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003; 88(2): 327-331. (Pubitemid 36119906)
16. Li YC. Inhibition of renin: An updated review of the development of renin inhibitors. Curr Opin Investig Drugs 2007; 8(9): 750-757. (Pubitemid 47345531)
17. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25- Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110(2): 229-238. (Pubitemid 34787360)
18. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase. Proc Natl Acad Sci USA 2008; 105(41): 15896-15901.
19. Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G et al. Long-term therapeutic effect of vitamin d analog doxercalciferol on diabetic nephropathy: Strong synergism with at1 receptor antagonist. Am J Physiol Renal Physiol 2009; 297(3): F791-F801.
20. Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986; 105(5): 649-654. (Pubitemid 17176965)
21. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Clin Chim Acta 2010; 411(17-18): 1354-1360.
22. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010; 55(5): 1283-1288.
23. Hollenberg NK, Williams GH, Taub KJ, Ishikawa I, Brown C, Adams DF. Renal vascular response to interruption of the renin-angiotensin system in normal man. Kidney Int 1977; 12(4): 285-293. (Pubitemid 8201773)
24. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK. Defect in the sodiummodulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 1983; 72(6): 2115-2124. (Pubitemid 14224417)
25. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin J et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14(2): 199-207. (Pubitemid 26121862)
26. Faloia E, Gatti C, Camilloni MA, Mariniello B, Sardu C, Garrapa GG et al. Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects. J Endocrinol Invest 2002; 25(4): 309-314. (Pubitemid 34436124)
27. Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK. Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 2005; 46(6): 1316-1320. (Pubitemid 43189729)
28. Chamarthi B, Williams JS, Williams GH. A mechanism for salt-sensitive hypertension: Abnormal dietary sodium-mediated vascular response to angiotensin-II. J Hypertens 2010; 28(5): 1020-1026.
29. Lely AT, Krikken JA, Bakker SJ, Boomsma F, Dullaart RP, Wolffenbuttel BH et al. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab 2007; 92(5): 1821-1826. (Pubitemid 46997195)
30. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003; 88(1): 157-161. (Pubitemid 36115158)
31. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: A populationbased study in older men and women. J Clin Endocrinol Metab 2005; 90(7): 4119-4123. (Pubitemid 41058184)
32. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M et al. Association of plasma vitamin d levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 2009; 94(9): 3306-3313.
33. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL et al. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes 2010; 59(1): 242-248.
34. Raji A,Williams GH, Jeunemaitre X, Hopkins PN, Hunt SC, Hollenberg NK et al. Insulin resistance in hypertensives: Effect of salt sensitivity, renin status and sodium intake. J Hypertens 2001; 19(1): 99-105. (Pubitemid 32099281)
35. Williams JS,Williams GH, Jeunemaitre X, Hopkins PN, Conlin PR. Influence of dietary sodium on the reninangiotensin- aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria. J Hum Hypertens 2005; 19(2): 133-138. (Pubitemid 40227370)
36. Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey III (NHANES 1988-94) Reference Manuals and Reports [CD-ROM]. National Center for Health Statistics 1996 Bethesda, MD.
37. Dickinson BD, Havas S. Reducing the population burden of cardiovascular disease by reducing sodium intake: A report of the Council on Science and Public Health. Arch Intern Med 2007; 167(14): 1460-1468. (Pubitemid 47124176)
38. Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998; 32(6): 965-971. (Pubitemid 29001421)
39. Lind L, Wengle B, Wide L, Ljunghall S. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens 1989; 2(1): 20-25. (Pubitemid 19031898)
40. Achinger SG, Ayus JC. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl 2005; 95): S37-S42. (Pubitemid 43361555)
41. Vaidya A, Forman JP. Vitamin D and hypertension: Current controversies and future directions. Hypertension 2010; 56(5): 774-779.
42. Danser AH. Local renin-angiotensin systems. Mol Cell Biochem 1996; 157(1-2): 211-216. (Pubitemid 26142454)
43. Price DA, Fisher ND, Lansang MC, Stevanovic R, Williams GH, Hollenberg NK. Renal perfusion in blacks: Alterations caused by insuppressibility of intrarenal renin with salt. Hypertension 2002; 40(2): 186-189. (Pubitemid 34840096)
44. Hollenberg NK, Williams GH. Abnormal renal function, sodium-volume homeostasis and renin systm behavior in normal-renin essential hypertension: The evolution of the non-modulation concept. In: Laragh and BM Brenner (eds). Hypertension: Pathophysiology, Diagnosis, and Management. Raven Press, Ltd: New York, 1995, 1837-1856.
45. Price DA, Fisher ND. The renin-angiotensin system in blacks: Active, passive, or what? Curr Hypertens Rep 2003; 5(3): 225-230.
46. Forman JP, Price DA, Stevanovic R, Fisher ND. Racial differences in renal vascular response to angiotensin blockade with captopril or candesartan. J Hypertens 2007; 25(4): 877-882. (Pubitemid 46398884)
47. Resnick LM. Calciotropic hormones in human and experimental hypertension. Am J Hypertens 1990; 3(8 Part 2): 171S-178S. (Pubitemid 20287347)
48. Resnick LM. Calciotropic hormones in salt-sensitive essential hypertension: 1,25-dihydroxyvitamin D and parathyroid hypertensive factor. J Hypertens Suppl 1994; 12(1): S3-S9. (Pubitemid 24082253)